Výsledky vyhledávání

MOdified NARanjo Causality Scale for ICSRs (MONARCSi): A Decision Support Tool for Safety Scientists

Autor: Darren Dorrell, Shawman Meireis, Shaun Comfort, J. T. Fine

Publikováno v: Drug Safety

Introduction Within the field of Pharmacovigilance, the most common approaches for assessing causality between a report of a drug and a corresponding adverse event are clinical judgment, probabilistic methods and algorithms. Although multiple methods

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25a04be19fd7eb7424c4f9552e780097
https://doi.org/10.1007/s40264-018-0690-y

Zobrazit plný text záznamu

Sorting Through the Safety Data Haystack: Using Machine Learning to Identify Individual Case Safety Reports in Social-Digital Media

Autor: Cartic Ramakrishnan, Sujan Perera, Meenakshi Nagarajan, J. T. Fine, Shawman Meireis, Shaun Comfort, Zoe Hudson, Darren Dorrell

Publikováno v: Drug Safety

Introduction There is increasing interest in social digital media (SDM) as a data source for pharmacovigilance activities; however, SDM is considered a low information content data source for safety data. Given that pharmacovigilance itself operates

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed4de2a13f782497bbdf4dfc924adf93
http://europepmc.org/articles/PMC5966485

Zobrazit plný text záznamu

Driving ability reported by neovascular age-related macular degeneration patients after treatment with ranibizumab

Autor: James Ward, J. T. Fine, Ivan J. Suñer, Chantal M. Dolan, Tsontcho Ianchulev, Neil M. Bressler, Paul P. Lee, Rohit Varma, Tom S. Chang

Publikováno v: Ophthalmology. 120(1)

To determine the impact of ranibizumab on driving status, driving ability perception, and having 20/40 vision or better in patients with choroidal neovascularization resulting from age-related macular degeneration (AMD).Phase III, multicenter, random

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a64655a840847df2a222e34e58e7bb56
https://pubmed.ncbi.nlm.nih.gov/23009891

Zobrazit plný text záznamu

Improved vision-related function after ranibizumab vs photodynamic therapy: a randomized clinical trial

Autor: Tom S. Chang, J. T. Fine, James Ward, Neil M. Bressler, Chantal M. Dolan

Publikováno v: Archives of ophthalmology (Chicago, Ill. : 1960). 127(1)

Objective To compare patient-reported visual function in those with neovascular age-related macular degeneration treated with ranibizumab or verteporfin photodynamic therapy (PDT). Design Multicenter, double-masked, phase 3 trial (ANCHOR). Participan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc45e9cafa5903423523b8c5da3f3374
https://pubmed.ncbi.nlm.nih.gov/19139332

Zobrazit plný text záznamu

The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis

Autor: Timothy D. Henry, Amy Chen Rundle, James T. Willerson, Frank J. Giordano, Brian H. Annex, Daniel S. Berman, Edward R. McCluskey, John J. Lopez, George R. McKendall, Alex Bajamonde, J. T. Fine, Prediman K. Shah, C. Michael Gibson, Raymond L. Benza, Michael Azrin

Publikováno v: Circulation. 107(10)

Background— Recombinant human vascular endothelial growth factor protein (rhVEGF) stimulates angiogenesis in animal models and was well tolerated in Phase I clinical trials. VIVA (Vascular endothelial growth factor in Ischemia for Vascular Angiogen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668faac8c4bf6808834eea633b109d6b
https://pubmed.ncbi.nlm.nih.gov/12642354

Zobrazit plný text záznamu

Prevalence of and Risk Factors for Diabetic Macular Edema in the United States

Autor: Quan V. Doan, Elizabeth Selvin, Neil M. Bressler, Chantal M. Dolan, Mark D. Danese, J. T. Fine, Shoshana Colman, Julie K. Bower, Adam Turpcu, Michelle Gleeson, Rohit Varma

Publikováno v: JAMA Ophthalmology. 132:1334

Importance Diabetic macular edema (DME) is a leading cause of vision loss in persons with diabetes mellitus. Although there are national estimates for the prevalence of diabetic retinopathy and its risk factors among persons with diabetes, to our kno

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca2967529cec434763a1a6e8cc6eb8bd
https://doi.org/10.1001/jamaophthalmol.2014.2854

Zobrazit plný text záznamu

Underuse of the Health Care System by Persons With Diabetes Mellitus and Diabetic Macular Edema in the United States

Autor: J. T. Fine, Shoshana Colman, Julie K. Bower, Neil M. Bressler, Quan V. Doan, Michelle Gleeson, Adam Turpcu, Mark D. Danese, Elizabeth Selvin, Chantal M. Dolan, Rohit Varma

Publikováno v: JAMA Ophthalmology. 132:168

Importance Thickening of the center of the retina, diabetic macular edema (DME), is the most common cause of visual loss due to diabetes mellitus. Treatment of DME has improved dramatically, and the prompt diagnosis of DME and referral of these patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d3d130ff41d51636ff1d9a5438ce8dc
https://doi.org/10.1001/jamaophthalmol.2013.6426

Zobrazit plný text záznamu

Autor: M S, Litwin, J T, Fine, F, Dorey, R A, Figlin, A S, Belldegrun

Publikováno v: The Journal of urology. 157(5)

We assessed health related quality of life in patients with advanced renal cell carcinoma treated with nephrectomy and tumor infiltrating lymphocyte therapy in combination with interleukin-2.A total of 20 patients with advanced renal cell carcinoma w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b22427b8c01356a37278133f84b219db
https://pubmed.ncbi.nlm.nih.gov/9112487

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání